InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Catelani Michael, Chief Financial Officer. Insider active across 1 companies, notably Anixa Biosciences Inc. In total, 7 disclosures have been logged. Total volume traded: €19k. The latest transaction was filed on 29 April 2022 — J. Regulator: SEC (Form 4). The full history is free.
Declarations7 total
€2,8531,086 shares@ €2.62750.0030% mcap8.8% of flow
Common Stock
SEC:0001493152-22-011741:0·
€13,5025,500 shares@ €2.4550.014% mcap41.8% of flow
Common Stock
SEC:0001493152-22-010689:0·
Ideal exit: 16 Jan 2023 (T+270)
€5,8512,509 shares@ €2.33180.0062% mcap18.1% of flow
Common Stock
SEC:0001493152-22-010594:0·
Ideal exit: 15 Jan 2023 (T+270)
€2,569743 shares@ €3.45780.0027% mcap50.9% of flow
Common Stock
SEC:0001493152-21-026933·
€2,569743 shares@ €3.45780.0027% mcap8.0% of flow
Common Stock
SEC:0001493152-21-026933:0·
€2,4791,634 shares@ €1.51730.0026% mcap49.1% of flow
Common Stock
SEC:0001493152-21-010447·
€2,4791,634 shares@ €1.51730.0026% mcap7.7% of flow
Common Stock
SEC:0001493152-21-010447:0·
7 of 7 declarations
About Catelani Michael
Michael Catelani is the Chief Financial Officer and COO at Anixa Biosciences Inc. He is responsible for the financial management of the company, including financial planning, risk management, and financial reporting. His role is essential to ensure the financial health and sustainability of the organization. As President, he also contributes to the strategic direction of the company.
